Analyst Research
| Report Title | Price |
|---|---|
|
Trading Report for (BCR). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Market Edge
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
C R Bard Inc Comments On Q1 2012 Revenue Guidance; Issues Q1 2012 EPS Guidance In Line With Analysts' Estimates-Conference Call
C R Bard Inc announced that for first quarter of 2012, it expects constant currency sales growth to be 4%-7% and earnings per share (EPS), excluding items affecting comparability if any, to be $1.53-$1.57. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $733 million and EPS of $1.55 for first quarter of 2012.
Latest Developments for C R Bard Inc
- C R Bard Inc To Pay $48 Million To Settle Kickback Allegations-Reuters
- C R Bard Inc Issues Q2 2013 EPS Guidance Below Analysts' Estimates-Conference Call
- C R Bard Inc Issues Q1 2013 EPS Guidance Below Analysts' Estimates; Comments On Q1 2013 Revenue Guidance; Issues FY 2013 Guidance Mixed Guidance; Comments On FY 2014 EPS Guidance-Conference Call
- C R Bard Inc Comments On Q3 2012 Revenue Guidance; Issues Q3 2012 EPS Guidance In Line With Analysts' Estimates-Conference Call
Latest Key Developments in Medical
- Urban Ag Corp Announces It Has Entered Into The Final Stages Of Negotiations To Acquire Contractor Currently Generating $4,500,000 In Revenues
- HeartWare International Inc Receives Conditional Approval From FDA To Enroll Supplemental Patient Cohort In Destination Therapy Trial
- Euromedis Groupe SA Issues FY 2013 Revenue Guidance In Line with Analysts' Estimates; Comments on Operating Income Guidance
- MEGANESUPER CO LTD Announces Changes of President
- Share this
- Link this
- Digg this
Follow Reuters